☆ 4.7 Letter

A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitor

RHEUMATOLOGY (2016)

Get Full Text
Add to Collection

Journal

RHEUMATOLOGY
Volume 55, Issue 2, Pages 382-384

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/kev371

Keywords

-

Categories

Rheumatology

Funding

  1. National Institute for Health Research [NF-SI-0512-10105] Funding Source: researchfish

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.